Nephrotic syndrome registry to help track patient outcomes
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial sets up a tracking system (a registry) for people with nephrotic syndrome, to learn how the condition behaves in real life. It may help by improving how future care and studies are planned for patients with similar disease patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with nephrotic syndrome
- It can be from any underlying cause (the reason you got nephrotic syndrome does not matter)
- There are no listed exclusion reasons for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks children with nephrotic syndrome whose kidney disease does not respond to usual treatments. It aims to collect information and samples to better understand resistant forms of the condition.
This study looks at children’s experiences and understanding of nephrotic syndrome using questionnaires. It aims to learn what helps families and children, which could improve care over time.
This study aims to improve how doctors diagnose nephrotic syndrome by using a personalized workflow. If you have nephrotic syndrome and are under 40 years old, this trial might help find the best treatment for your specific type.
This study looks at substances in the blood of people with nephrotic syndrome, a condition that causes protein to leak into the urine. It may help doctors understand the disease better.
This study enrolls people who are already on peritoneal dialysis to track care and outcomes over time. It may help improve how peritoneal dialysis is delivered in the future.
This study collects health information from people with chronic kidney disease (CKD) and also from some people without CKD but with kidney risk factors. It helps doctors understand how CKD develops and how it’s managed in everyday life, not to test a new drug.
Hear when a new Nephrotic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.